Teleflex Incorporated (TFX)
NYSE: TFX · Real-Time Price · USD
118.26
+0.73 (0.62%)
Jun 18, 2025, 1:53 PM - Market open
Teleflex Employees
Teleflex had 14,100 employees as of December 31, 2024. The number of employees decreased by 400 or -2.76% compared to the previous year.
Employees
14,100
Change (1Y)
-400
Growth (1Y)
-2.76%
Revenue / Employee
$213,485
Profits / Employee
$10,595
Market Cap
5.23B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
TFX News
- 6 days ago - New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients - GlobeNewsWire
- 7 days ago - Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men's Health Month - GlobeNewsWire
- 4 weeks ago - Teleflex Publishes 2024 Global Impact Report - GlobeNewsWire
- 4 weeks ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teleflex Incorporated (TFX) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 4 weeks ago - Teleflex Showcases New Clinical Data Presented at the 2025 American Urological Association (AUA) Annual Meeting - GlobeNewsWire
- 5 weeks ago - Teleflex Incorporated (TFX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 5 weeks ago - Bronstein, Gewirtz & Grossman, LLC Encourages Teleflex Incorporated (TFX) Shareholders to Inquire about Securities Investigation - Accesswire
- 5 weeks ago - New Retrospective Study Reports Significantly Reduced Post-Operative GERD Rates with the Titan SGS™ Stapler from Teleflex Compared with Multi-Fire Staplers in Sleeve Gastrectomy - GlobeNewsWire